Should they be context/disease specific?
Should the use of chemotherapy before/after, or during radiotherapy modify these tolerances?
Contexts: extramedullary vs. intradural extramedullary vs. intramedullary tumors
Diseases: low vs. high grade primary solid tumor/sarcoma or low vs. high grade primary CNS tumors
Chemotherapy: are there agents which are considered high risk for myelopathy when combined with radiotherapy?